RLAY News and Press, Relay Therapeutics Inc. From 08/27/20

Relay Therapeutics (NASDAQ: RLAY ) : Q2 GAAP EPS of -$6.06 misses by $5.03 . Cash, cash equivalents and investments totaled $312M as of June 30, 2020 $312M Press Release More news on: Relay Therapeutics, Inc., Earnings news and commentary,

CAMBRIDGE, Mass., Aug. 27, 2020 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by leveraging unparalleled insights into protein motion, today reported second quarter 2020 financial results. ...

After an active July, the US IPO market is taking a breather. Three companies are scheduled to raise $2.5 billion in the week ahead, led by Chinese real estate giant KE Holdings (BEKE). KE Holdings, China's largest housing platform operating under the Lianjia and Beike brands, plans to raise...

Point Roberts, WA and Delta, BC - July 31, 2020 (Investorideas.com Newswire) Investorideas.com , a global news source and leading retail investor resource announces its weekly roundup of stocks added to its global stock directories, including biotech and mining. This week's new biotech compan...